The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
dc.contributor.author | Ripley, R | |
dc.contributor.author | Richards, S | |
dc.contributor.author | Wilberforce, S | |
dc.contributor.author | Chen, ZM | |
dc.contributor.author | vanGijn, J | |
dc.contributor.author | Harrison, M | |
dc.contributor.author | Wilhelmsen, L | |
dc.contributor.author | Warlow, C | |
dc.contributor.author | Anderson, S | |
dc.contributor.author | Bowie, A | |
dc.contributor.author | Boyle, J | |
dc.contributor.author | Brownlie, A | |
dc.contributor.author | Charlton, D | |
dc.contributor.author | Cranswick, G | |
dc.contributor.author | Day, L | |
dc.contributor.author | Dennis, M | |
dc.contributor.author | Dorman, P | |
dc.contributor.author | Fraser, H | |
dc.contributor.author | Kaye, M | |
dc.contributor.author | Lindley, R | |
dc.contributor.author | Liu, M | |
dc.contributor.author | MacDonald, C | |
dc.contributor.author | McCrindle, I | |
dc.contributor.author | Middleton, G | |
dc.contributor.author | Perry, D | |
dc.contributor.author | Scoltock, V | |
dc.contributor.author | Smith, B | |
dc.contributor.author | Taylor, H | |
dc.contributor.author | Waddell, F | |
dc.contributor.author | Sandercock, P | |
dc.contributor.author | Collins, R | |
dc.contributor.author | Counsell, C | |
dc.contributor.author | Farrell, B | |
dc.contributor.author | Peto, R | |
dc.contributor.author | Slattery, J | |
dc.contributor.author | Wardlaw, J | |
dc.contributor.author | Crowther, J | |
dc.contributor.author | Heineman, J | |
dc.contributor.author | Knight, S | |
dc.contributor.author | Radley, A | |
dc.date.accessioned | 2021-03-03T17:20:35Z | |
dc.date.available | 2021-03-03T17:20:35Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Sandercock P., Collins R., Counsell C., Farrell B., Peto R., Slattery J., Warlow C., Anderson S., Bowie A., Boyle J., et al., "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke", LANCET, cilt.349, sa.9065, ss.1569-1581, 1997 | |
dc.identifier.issn | 0140-6736 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_493bca1d-778e-4348-849a-3efd755ea836 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/52685 | |
dc.identifier.uri | https://doi.org/10.1016/s0140-6736(97)04011-7 | |
dc.description.abstract | Background Only a few small trials have compared antithrombotic therapy (antiplatelet or anticoagulant agents) versus control in acute ischaemic stroke, and none has been large enough to provide reliable evidence on safety or efficacy. | |
dc.language.iso | eng | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke | |
dc.type | Makale | |
dc.relation.journal | LANCET | |
dc.contributor.department | , , | |
dc.identifier.volume | 349 | |
dc.identifier.issue | 9065 | |
dc.identifier.startpage | 1569 | |
dc.identifier.endpage | 1581 | |
dc.contributor.firstauthorID | 90147 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Makale [92796]